Your cart
  • Your shopping cart is empty!

Alpha Synuclein Oligomers (Dop...

Article
Alpha Synuclein Oligomers (Dopamine HCL Stabilized)
Product Number
SPR-466E
Supplier
StressMarq Biosciences
Size
5 x 100 ug
Description
Alpha-Synuclein (SNCA) is expressed predominantly in the brain, where it is concentrated in presynaptic nerve terminals (1). Alpha-synuclein is highly expressed in the mitochondria of the olfactory bulb, hippocampus, striatum and thalamus (2). Functionally, it has been shown to significantly interact with tubulin (3), and may serve as a potential microtubule-associated protein. It has also been found to be essential for normal development of the cognitive functions, inactivation may lead to impaired spatial learning and working memory (4). SNCA fibrillar aggregates represent the major non A-beta component of Alzheimers disease amyloid plaque, and a major component of Lewy body inclusions, and Parkinson's disease. Parkinson's disease (PD) is a common neurodegenerative disorder characterized by the progressive accumulation in selected neurons of protein inclusions containing alpha-synuclein and ubiquitin (5, 6). Dopamine inhibits alpha synuclein fibrillogenesis leading to oligomer accumulation in vitro (7), (8) and in vivo (9), (10).
Category
Proteins, Peptides and Small Molecules
Product Group
Proteins
Application
Func, In Vivo Assay, SDS-PAGE, WB
Purity
>95%
Molecular Weight
~14.46kDa
Synonyms
alpha-synuclein; I+/--synuclein; NACP; non A-beta component of AD amyloid; PARK1; PARK4; PD1; synuclein alpha-140; synuclein, alpha (non A4 component of amyloid precursor); truncated alpha synuclein; Non-A beta component of AD amyloid; Non-A4 component of amyloid precursor
Unigene ID
6622
Gene Symbols
SNCA
Shipping Temperature
DRY ICE
Supplier URL
Visit supplier product page

Main Menu

Account